Torrent Pharmaceuticals Limited
HDFC Mutual Fund increased its stake in Torrent Pharmaceuticals from 1.18% to 2.18%, buying 37,94,495 shares. The value of the additional shares is ₹180.59 crore, at a share price of ₹4763.00.
A leading Indian pharmaceutical company engaged in research, development, manufacturing and marketing of generic formulations across multiple therapeutic areas. Torrent Pharma operates through a diversified portfolio serving both domestic and international markets, with a focus on affordable healthcare solutions. The company distinguishes itself through its vertically integrated operations, advanced manufacturing facilities, and commitment to delivering quality pharmaceutical products that meet global standards.
One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.